Texas 2017 - 85th Regular

Texas Senate Bill SB1284

Voted on by Senate
 
Out of House Committee
 
Voted on by House
 
Governor Action
 
Bill Becomes Law
 

Caption

Relating to prescriber and dispenser reporting and access to patient prescription information under the Texas Controlled Substances Act.

Impact

One significant impact of SB1284 is its potential to help mitigate prescription drug abuse by creating a more robust monitoring framework for prescriptions. By requiring electronic transfers and detailed reporting of prescriptions, the bill aims to discourage harmful prescribing patterns or practices which could indicate drug diversion or abuse. Furthermore, the legislation encourages collaboration between healthcare providers and regulatory bodies, fostering a system that aims to identify troubling trends in prescription behavior, thus promoting overall public health.

Summary

SB1284, also known as the Texas Controlled Substances Act amendment, aims to enhance the prescriber and dispenser reporting requirements for controlled substances. The bill includes specific provisions about how and when practitioners must report prescriptions to the state board. For example, it mandates that practitioners communicate emergency oral prescriptions to the board within a set timeframe and ensures that all prescription transmissions to pharmacists are documented consistently, regardless of whether they occur in person or electronically. This promotes accountability and improves the tracking of prescription drugs throughout the state.

Contention

A notable point of contention surrounding the bill is the balance it seeks to strike between regulatory oversight and access to care. While proponents argue that these measures will enhance patient safety and reduce the risk of addiction to controlled substances, opponents express concerns that overly stringent regulations could hamper legitimate patient access to necessary medications. Moreover, there is discussion about the administrative burden it places on healthcare providers, particularly in terms of additional reporting requirements and the potential for errors in urgent care situations.

Companion Bills

No companion bills found.

Previously Filed As

TX HB2767

Relating to the sharing of controlled substance prescription monitoring information between the Texas State Board of Pharmacy and the Health and Human Services Commission for the state Medicaid program.

TX HB343

Relating to the prescriptive authority of certain psychologists; authorizing a fee.

TX HB5298

Relating to a pilot program under which lockable, tamper-evident containers are used by participating pharmacies when dispensing schedule II controlled substances.

TX HB814

Relating to an acknowledgment on receipt of an opioid prescription drug.

TX HB2967

Relating to the prescription of a controlled substance for certain patients and continued treatment of those patients.

TX HB2995

Relating to the prescribing of medical cannabis for medical use to certain veterans with combat-related injuries or medical conditions and the licensing of dispensing organizations under the Texas Compassionate Use Program.

TX SB2173

Relating to a pilot program for the safe disposal of prescription drugs, including controlled substance prescription drugs.

TX HB4341

Relating to promoting, prescribing, administering, or dispensing prescription drugs for off-label use.

TX HB972

Relating to warning labels for opioid prescription drugs.

TX HB816

Relating to warning labels for opioid prescription drugs.

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

TX SB1233

Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.